<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: <z:e sem="disease" ids="C0022104" disease_type="Disease or Syndrome" abbrv="IBS">Irritable bowel syndrome</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IBS</z:e>) and <z:e sem="disease" ids="C0267167" disease_type="Disease or Syndrome" abbrv="">functional dyspepsia</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FD</z:e>) are highly prevalent in the general population as does <z:hpo ids='HP_0002020'>gastroesophageal reflux disease</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Therefore, it is expected that these conditions may frequently overlap </plain></SENT>
<SENT sid="2" pm="."><plain>OBJECTIVE: We aimed at evaluating the presence ofFD and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IBS</z:e> symptoms in patients with erosive (ERD), non-erosive reflux disease (NERD) and <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (BE) </plain></SENT>
<SENT sid="3" pm="."><plain>PATIENTS AND METHODS: 71 patients presenting at the reflux disease outpatient clinic were prospectively included in this study </plain></SENT>
<SENT sid="4" pm="."><plain>33 patients had NERD, 25 ERD and 13 BE according to the Montreal classification </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients with ERD and NERD had typical reflux symptoms, as assessed by a validated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> questionnaire (RDQ) </plain></SENT>
<SENT sid="6" pm="."><plain>The diagnosis of <z:e sem="disease" ids="C0267167" disease_type="Disease or Syndrome" abbrv="">functional dyspepsia</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IBS</z:e> symptoms was assessed according to the Rome III criteria </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IBS</z:e> symptoms (<z:mp ids='MP_0009247'>bloating</z:mp>, <z:hpo ids='HP_0002027'>abdominal pain</z:hpo>, <z:hpo ids='HP_0002019'>constipation</z:hpo> and <z:hpo ids='HP_0002014'>diarrhea</z:hpo>) were slightly more prevalent in NERD (54.6, 63.6, 21.20, 24.2%, respectively) than in ERD (48.0, 44.0, 12.0, 20.0%, respectively) and in BE (53.9, 23.10, 15,4, 23.1%, respectively), but none of these differences reached statistical significance </plain></SENT>
<SENT sid="8" pm="."><plain>NERD patients had more <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FD</z:e> symptoms than patients with ERD or BE, but again this difference did not reach statistical significance </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: Our data show that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IBS</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FD</z:e> are common in the entire spectrum of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>The presence of these disorders might explain why many patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> are deemed as treatment failures if they have no complete symptom relief with <z:chebi fb="0" ids="49200">proton pump inhibitors</z:chebi> </plain></SENT>
</text></document>